West Pharmaceutical Services Inc
Close on Nov 20, 2026Market cap $27.19BP/E 43.8Yield 0.22%
West Pharmaceutical Services Prior-Year Contract Liabilities Recognized as Revenue by Quarter
Prior-Year Contract Liabilities Recognized as Revenue ($M)
West Pharmaceutical Services Prior-Year Contract Liabilities Recognized as Revenue: $23.1M in Q1 2026, up 26.2% from a year earlier.
Where the Q1 2026 figure comes from
Source: West Form 10-Q (FY2026Q1, filed 2026-04-23) ↗
Reported in Form 10-K Note 3 (Revenue).
quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Prior-Year Contract Liabilities Recognized as Revenue ($M) | Year on year | Source |
|---|---|---|---|---|
| Q1 2026 | Mar 31, 2026 | 23.1 | +26.2% | West Form 10-Q (FY2026Q1, filed 2026-04-23) ↗ |
| Q1 2025 | Mar 31, 2025 | 18.3 | +18.1% | West Form 10-Q (FY2025Q1, filed 2025-04-24) ↗ |
| Q1 2024 | Mar 31, 2024 | 15.5 | -27.2% | West Form 10-Q (FY2024Q1, filed 2024-04-25) ↗ |
| Q1 2023 | Mar 31, 2023 | 21.3 | +119.6% | West Form 10-Q (FY2023Q1, filed 2023-04-27) ↗ |
| Q1 2022 | Mar 31, 2022 | 9.70 | -44.3% | West Form 10-Q (FY2022Q1, filed 2022-04-28) ↗ |
| Q1 2021 | Mar 31, 2021 | 17.4 | +70.6% | West Form 10-Q (FY2021Q1, filed 2021-04-30) ↗ |
| Q1 2020 | Mar 31, 2020 | 10.2 | -60.5% | West Form 10-Q (FY2020Q1, filed 2020-04-24) ↗ |
| Q1 2019 | Mar 31, 2019 | 25.8 | – | West Form 10-Q (FY2019Q1, filed 2019-05-08) ↗ |
Cite this data
StockData. (2026). West Pharmaceutical Services Prior-Year Contract Liabilities Recognized as Revenue ($M), quarterly Q1 2019–Q1 2026 [Data set]. Compiled from West Pharmaceutical Services SEC filings and investor materials. https://stockdatahq.com/stocks/wst/kpis/deferred-rev-recognized
See every metric in the West Pharmaceutical Services KPI table. Data updated Nov 9, 2026.
See a number that looks wrong?